Correlation Between HCW Biologics and Alterity Therapeutics

Can any of the company-specific risk be diversified away by investing in both HCW Biologics and Alterity Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining HCW Biologics and Alterity Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between HCW Biologics and Alterity Therapeutics, you can compare the effects of market volatilities on HCW Biologics and Alterity Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in HCW Biologics with a short position of Alterity Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of HCW Biologics and Alterity Therapeutics.

Diversification Opportunities for HCW Biologics and Alterity Therapeutics

-0.27

Correlation Coefficient

HCW Biologics  Alterity Therapeutics

Very good diversification

The 3 months correlation between HCW and Alterity is -0.27. Overlapping area represents the amount of risk that can be diversified away by holding HCW Biologics and Alterity Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alterity Therapeutics and HCW Biologics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on HCW Biologics are associated (or correlated) with Alterity Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alterity Therapeutics has no effect on the direction of HCW Biologics i.e., HCW Biologics and Alterity Therapeutics go up and down completely randomly.

Pair Corralation between HCW Biologics and Alterity Therapeutics

Given the investment horizon of 90 days HCW Biologics is expected to generate 1.2 times less return on investment than Alterity Therapeutics. In addition to that, HCW Biologics is 1.81 times more volatile than Alterity Therapeutics. It trades about 0.01 of its total potential returns per unit of risk. Alterity Therapeutics is currently generating about 0.03 per unit of volatility. If you would invest  395.00  in Alterity Therapeutics on October 25, 2024 and sell it today you would lose (61.00) from holding Alterity Therapeutics or give up 15.44% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	99.39%
Values	Daily Returns

HCW Biologics  vs.  Alterity Therapeutics

HCW Biologics

Risk-Adjusted Performance

5 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in HCW Biologics are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, HCW Biologics sustained solid returns over the last few months and may actually be approaching a breakup point.

Alterity Therapeutics

Risk-Adjusted Performance

21 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Alterity Therapeutics are ranked lower than 21 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak technical indicators, Alterity Therapeutics exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with HCW Biologics and Alterity Therapeutics

The main advantage of trading using opposite HCW Biologics and Alterity Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if HCW Biologics position performs unexpectedly, Alterity Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alterity Therapeutics will offset losses from the drop in Alterity Therapeutics' long position.

The idea behind HCW Biologics and Alterity Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.